Government Buys Continuing Supply of IMVAMUNE Smallpox Vaccine

Homeland Security Today: Existing doses of Bavarian Nordic’s IMVAMUNE Smallpox vaccine in the Strategic National Stockpile (SNS) are being replenishment by an option valued at $118 million that was awarded to the company by the Department of Health & Human Services’s (HHS) Biomedical Advanced Research and Development Authority (BARDA).

Read article